JP2011511075A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511075A5
JP2011511075A5 JP2010545891A JP2010545891A JP2011511075A5 JP 2011511075 A5 JP2011511075 A5 JP 2011511075A5 JP 2010545891 A JP2010545891 A JP 2010545891A JP 2010545891 A JP2010545891 A JP 2010545891A JP 2011511075 A5 JP2011511075 A5 JP 2011511075A5
Authority
JP
Japan
Prior art keywords
alkyl
unsubstituted
alkoxy
phenyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010545891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011511075A (ja
JP5704925B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/000810 external-priority patent/WO2009099670A2/en
Publication of JP2011511075A publication Critical patent/JP2011511075A/ja
Publication of JP2011511075A5 publication Critical patent/JP2011511075A5/ja
Application granted granted Critical
Publication of JP5704925B2 publication Critical patent/JP5704925B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010545891A 2008-02-08 2009-02-06 オリゴマー−カンナビノイドコンジュゲート Expired - Fee Related JP5704925B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6508908P 2008-02-08 2008-02-08
US61/065,089 2008-02-08
PCT/US2009/000810 WO2009099670A2 (en) 2008-02-08 2009-02-06 Oligomer-cannabinoid conjugates

Publications (3)

Publication Number Publication Date
JP2011511075A JP2011511075A (ja) 2011-04-07
JP2011511075A5 true JP2011511075A5 (enExample) 2013-01-31
JP5704925B2 JP5704925B2 (ja) 2015-04-22

Family

ID=40602328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010545891A Expired - Fee Related JP5704925B2 (ja) 2008-02-08 2009-02-06 オリゴマー−カンナビノイドコンジュゲート

Country Status (4)

Country Link
US (2) US8829043B2 (enExample)
EP (1) EP2254601B1 (enExample)
JP (1) JP5704925B2 (enExample)
WO (1) WO2009099670A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8829043B2 (en) 2008-02-08 2014-09-09 Nektar Therapeutics Oligome-cannabinoid conjugates
WO2011006099A1 (en) * 2009-07-10 2011-01-13 Northeastern University Angiogenic resorcinol derivatives
EP2654799B1 (en) 2010-12-23 2017-11-08 Nektar Therapeutics Polymer-sunitinib conjugates
US10220020B2 (en) 2010-12-23 2019-03-05 Nektar Therapeutics Polymer-des-ethyl sunitinib conjugates
RU2641916C2 (ru) 2012-10-02 2018-01-23 Байер Кропсайенс Аг Гетероциклические соединения в качестве пестицидов
EP3538078A4 (en) * 2016-11-11 2020-07-08 Bennes, Inc. FORMULATIONS FOR EFFICIENT CANNABINOID DELIVERY
EP3600361A4 (en) 2017-03-24 2021-01-06 Trait Biosciences, Inc. High level in vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems
AU2018301674B2 (en) 2017-07-11 2024-03-28 Trait Biosciences, Inc. Generation of water-soluble cannabinoid compounds in yeast and plant cell suspension cultures and compositions of matter
US11905543B2 (en) 2017-07-11 2024-02-20 Trait Biosceinces, Inc. In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures
US11946059B2 (en) 2017-07-11 2024-04-02 Trait Biosciences, Inc. In vivo generation of water-soluble cannabinoids in plant cell suspension cultures
KR20220012298A (ko) * 2019-05-23 2022-02-03 카레 케미컬 테크놀로지스 인코포레이티드 촉매 칸나비노이드 공정 및 전구체
CA3145109A1 (en) * 2019-06-24 2020-12-30 Diverse Biotech, Inc. Cannabinoid conjugate molecules
WO2020263975A1 (en) 2019-06-24 2020-12-30 Diverse Biotech, Inc. Beta-lactam-cannabinoid conjugate molecules
US12485181B2 (en) * 2019-06-28 2025-12-02 Serina Therapeutics (Al), Inc. Polyoxazoline-drug conjugates with novel pharmacokinetic properties
CN110372627B (zh) * 2019-07-04 2022-12-06 南昌大学 一种1,3,4-噁二唑衍生物及其制备方法和应用
AU2020366257B2 (en) * 2019-10-15 2025-01-23 Diverse Biotech, Inc. Conjugate molecules
US11091447B2 (en) 2020-01-03 2021-08-17 Berg Llc UBE2K modulators and methods for their use
WO2021211915A1 (en) * 2020-04-17 2021-10-21 University Of Connecticut Polycannabinoids, compounds, compositions and methods of use
CN112592260A (zh) * 2020-11-30 2021-04-02 云南苏理生物医药科技有限公司 一种大麻二酚的合成方法
WO2023102655A1 (en) * 2021-12-09 2023-06-15 Kare Chemical Technologies Inc. Catalytic tetrahydrocannabinol synthesis and precursors
CN115784836A (zh) * 2022-12-08 2023-03-14 南京康立瑞生物科技有限公司 一种高选择性的制备反式-薄荷基-2,8-二烯-1-醇的方法
WO2025034533A1 (en) 2023-08-04 2025-02-13 University Of Connecticut Natural and synthetic cannabinoids as fluorescent tags; compositions, methods, and applications

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968125A (en) * 1973-11-05 1976-07-06 Eli Lilly And Company Dihydroxyhexahydrodibenzo[b,d]pyrans
AU8763275A (en) * 1975-01-13 1977-06-23 Abbott Lab Tri-cyclic compounds derived from phloroglucinol
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5532237A (en) * 1995-02-15 1996-07-02 Merck Frosst Canada, Inc. Indole derivatives with affinity for the cannabinoid receptor
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
FR2741621B1 (fr) * 1995-11-23 1998-02-13 Sanofi Sa Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
EP1109533A1 (en) * 1999-07-08 2001-06-27 Orlando Hung Pulmonary delivery of liposome-encapsulated cannabinoids
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
MXPA05002620A (es) 2002-09-09 2005-05-05 Nektar Therapeutics Al Corp Alcanales polimericos solubles en agua.
BR0316332A (pt) 2002-12-02 2005-09-27 Astellas Pharma Inc Composto pirazólico, composição farmacêutica e agente analgésico contendo o mesmo, processo para sua preparação e seu uso e pacote comercial
FR2854896B1 (fr) * 2003-05-16 2007-08-17 Mayoly Spindler Lab Nouveaux tensioactifs, compositions les comprenant
EA018427B1 (ru) 2003-12-16 2013-07-30 Нектар Терапьютикс Химически модифицированный налоксон
JP2006316054A (ja) 2005-04-15 2006-11-24 Tanabe Seiyaku Co Ltd 高コンダクタンス型カルシウム感受性kチャネル開口薬
JP5069894B2 (ja) * 2005-10-21 2012-11-07 田辺三菱製薬株式会社 ピラゾール化合物
EP1951678A1 (en) * 2005-10-21 2008-08-06 Mitsubishi Tanabe Pharma Corporation Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity
EP2176208B1 (en) 2007-07-30 2015-01-21 Zynerba Pharmaceuticals, Inc. Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
MX2010005931A (es) 2007-11-30 2010-06-15 Alltranz Inc Profarmacos de tetrahidrocanabinol, composiciones que comprenden profarmacos de tetrahidrocanabinol y metodos para utilizar los mismos.
US8829043B2 (en) 2008-02-08 2014-09-09 Nektar Therapeutics Oligome-cannabinoid conjugates

Similar Documents

Publication Publication Date Title
JP2011511075A5 (enExample)
JP2011500545A5 (enExample)
CZ228295A3 (en) The use of carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
JP2016518437A5 (enExample)
JP2009515980A5 (enExample)
WO2005117890A3 (en) Thienopyrimidines and thiazolopyrimidines for use in medicine
JP2009536933A5 (enExample)
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
JP2016520618A5 (enExample)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
MX2009009473A (es) Compuestos para el tratamiento de hepatitis c.
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
JP2009536620A5 (enExample)
JP2012533546A5 (enExample)
JP2006501201A5 (enExample)
JP2010527913A5 (enExample)
JP2009523777A5 (enExample)
JP2010539179A5 (enExample)
MX2008002061A (es) Derivados de tiazolil piperidina utiles como moduladores del receptor h3.
ATE528306T1 (de) Benzoxazepin-verbindungen, ihre herstellung und verwendung
JP2011526247A5 (enExample)
JP2009520695A5 (enExample)
JP2013506674A5 (enExample)
JP2009541387A5 (enExample)
WO2008039406A3 (en) Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist